The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy is a research paper published in American Journal of Hematology (2021). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH Clinical Center
Grant: P01 CA23766
NIH Clinical Center
Grant: P30 CA008748
NCI NIH HHS
Grant: K12 CA184746
NCI NIH HHS
Grant: K08 CA215317
NCI NIH HHS
Grant: P50 CA254838
NCI NIH HHS
Grant: P01 CA023766
Fields of Study
MeSH Terms